-
Mashup Score: 1
A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Catheter Ablation as First-Line Therapy in Persistent AF - American College of Cardiology - 2 hour(s) ago
Thomas C. Crawford, MD, FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3Augmenting reality in echocardiography - 2 hour(s) ago
Echocardiography is a vital first-line imaging tool for the diagnosis and management of many cardiovascular diseases. Its availability and low cost have encouraged widespread use by clinicians for the diagnosis and management of patients with heart failure.1 Visual estimation is widely used to assess ejection fraction (EF), the percentage of blood the left ventricle pumps out during a contraction. Accurately determining the EF in patients with heart failure is crucial for the implementation of timely guideline-directed medical treatment. There is a substantial need for high-fidelity determination of EF in emergency settings. However, there is high interobserver variability with visual estimation methods, which can be compounded by inadequate quality of capture and lack of specialised training in both obtaining and interpreting echocardiograms in these settings.2 The work presented by Choi et al 3 represents an important advance in reducing the burden of time and cost constraints in mea
Source: heart.bmj.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE - 2 hour(s) ago
The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.
Source: cardiovascularbusiness.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Relationship of TAPSE Normalized by Right Ventricular Area With Pulmonary Compliance, Exercise Capacity, and Clinical Outcomes - 2 hour(s) ago
BACKGROUND: While tricuspid annular plane systolic excursion (TAPSE) captures the predominant longitudinal motion of the right ventricle (RV), it does not account for ventricular morphology and radia
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0TAVI Use Rising in Young US Patients, Yet Another Analysis Shows - 2 hour(s) ago
Several surgeons told TCTMD they’re highly critical of the trend, saying it’s time for an RCT of TAVI vs SAVR in those below age 65.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Best of AATS 2024: Congenital - 3 hour(s) ago
At the Forefront of Cardiothoracic Surgery, AATS members have a proven record of distinction within the specialty and have made significant contributions to the care and treatment of cardiothoracic disease.
Source: www.aats.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2
May 6, 2024—Medtronic announced it received approval from the National Medical Products Administration (NMPA) in China for its Symplicity Spyral
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 14FDA Update: Agency Qualifies Apple AFib History Feature as an MDDT - American College of Cardiology - 3 hour(s) ago
The U.S. Food and Drug Administration (FDA) announced on May 1 that the Apple Atrial Fibrillation (AFib) History Feature now qualifies as a Medical Device Development Tool (MDDT) to assess AFib burden estimates within clinical studies. This is the first digital health technology to qualify under the agency’s MDDT program for providing a noninvasive means of checking AFib burden estimates within clinical studies. According to the FDA, the Apple AFib History Feature can “be used as a biomarker test … as a
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Events - 3 hour(s) ago
MedAxiom is the cardiovascular community’s premier source for organizational performance solutions.
Source: www.medaxiom.comCategories: General Medicine News, Cardiology News and JournTweet-
Join us the next 3 weeks for our webinar series featuring startups from the 2023 HeartX Cohort! 🔍 Dive into the future of cardiology with 15 min presentations & Q&A sessions. @HealthTechAR Register individually for each session! Find all webinars here: https://t.co/xucIFedsCj https://t.co/gpM3OAeBPL
-
Cardiologists and surgeons makes history, perform world’s first robot-assisted TEER #cardiology #cardiotwitter #mitralvalve @JACCJournals https://t.co/OKJrVNYLrl